The US Department of Health and Human Services posted a draft policy that would ease restrictions about how certain peptides may be created in the US, essentially opening up access to them. Here's what to know about peptides and what the change could mean: https://t.co/EGrcKTWtM2
Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results. https://t.co/dWyMUgLGGb
🚨 BREAKING:
$HIMS
ANNOUNCES PEPTIDES+ SPECIALTY
- Will launch Sermorelin, Glutathione, B12, NAD+, and L-carnitine
- BPC-157 and TB-500 to follow soon
Sign up form also mentions semax, epitalon, KPV, and MOTS-C 👀
Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempic in a large diabetes study.
#Peptide#retatrutide
.
@SecKennedy
on peptides: "The Trump Administration believes in freedom of choice... Americans ought to be able to get them, but they should be able to get ones where they know what the purity is and they know that they have come from a safe environment."
$50 Billion Market. No Standard for Proof. Over 110 peptides are approved globally. Hundreds of suppliers. Most can't verify what's in the vial. The peptide therapeutics market is valued at $49.68 billion in 2026 - projected to reach $70.2 billion by 2031. In the United
The pharmaceutical industry is outsourcing more and more tasks. In addition to Lonza, this benefits the Swiss specialists Bachem, Siegfried, and Dottikon.Bachem, Siegfried und Dottikon.
At last week’s #STATSummit, Dana Senaha told the story of her husband’s experience participating in the clinical trial for daraxonrasib.
Watch: One family’s story of a life-extending medicine for pancreatic cancer
https://t.co/cx4dY5ceiq
Novo has struck a licensing deal with Vivtex Corporation for oral peptide and protein drugs to treat obesity diabetes and related conditions The company has focused much more on oral peptides and less on small molecules compared to competitor Eli Lilly
🔥 GLP-1 is more than just a weight-loss drug!
5 trials confirm: lower sugar · protect the heart · reduce risks
Semaglutide — blood risk scores dropped across the board
Scores are a signal. Results are the real proof.